// App-Quantinova.ai

: Higher Rate of Relapse of KSHV/HHV-8 Associated Multicentric Castleman Disease after Rituximab Therapy in HIV- Patients Than in HIV+ Patients

Researchers

Presenter

  • Eric Oksenhendler

Principal Investigators

  • Camille Rasmussen

  • David Boutboul

  • Lionel Galicier

  • laurence Gerard

Medical Centers

  • National Reference Center for Castleman Disease, Hôpital Saint-Louis, Paris, FRA

  • Centre de Réference National Maladie de Castleman, Paris, France

  • Department of Clinical Immunology, Hopital Saint-Louis, Paris, France

  • Paeris Université, Paris, France

Locations

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Castleman disease

  • Kaposi's sarcoma

  • Lymphomas

  • Sarcoma

Biomarkers

  • C reactive protein

  • Cancer antigen 15-3

  • Cluster of Differentiation 19

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved